Life Spine received FDA 510(k) clearance to market the PROLIFT® Expandable Interbody System for use in minimally invasive PLIF, TLIF and oblique approaches.
Medtronic commenced EU launch of AVILA™ devices, intended for use in open and minimally invasive anterior and oblique lumbar interbody fusion from L2-S1 levels.
On 4/20/16, FDA’s Orthopaedic and Rehabilitation Devices Panel will meet regarding the PMA for Cartiva’s Synthetic Cartilage Implant, an organic polymer-based biomaterial designed to mimic biologic cartilage.
OrthoSensor entered into a partnership with IM-Tech to support R&D collaboration, manufacturing and investments in electronics technology in the global commercialization of the VERASENSE™ sensor.
NuVasive entered into a definitive agreement to acquire Mega Surgical, its exclusive distributor in Brazil. The transaction is expected to close within 1Q16.
FDA has accepted for filing Vericel’s BLA for MACI™, matrix-applied characterized autologous cultured chondrocytes intended to treat adult symptomatic knee cartilage defects.
Stryker Spine announced FDA 510(k) clearance of Tritanium® PL, a highly-porous posterior lumbar cage manufactured via 3D additive manufacturing. Launch will occur in 2Q16.
Zimmer Biomet (ZBH) received FDA 510(k) clearance for compatibility of the Nexelâ„¢ Total Elbow with the Comprehensive® Segmental Revision System. This marks the 1st submission by ZBH to establish compatibility of two separate ZBH implant systems.Â